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14 NOVEMBER 2008, FRIDAY 
 
14:00-16:05 Meeting Room 201  Bilateral Scientific & Technological Cooperation Belgium-China 
        Biomarker of Liver Fibrosis and Liver Cancer:  
From Molecular Biology to Clinical Perspectives 
 
Chairpersons:  Hui Zhuang ( ), Beijing  
           Claude Libert, Ghent, Belgium 
 
Non-Invasive (Serum) Markers in the Diagnosis of Liver Fibrosis 
Hans Van Vlierberghe, Ghent, Belgium 
 
Insight into New Markers and Diagnostic Models on Hapatocellelar 
Carcinoma 
Chunfang Gao ( ), Shanghai 
 
The Ras Inhibitor Farnesylthiosalicyclic Acid (FTS) Prevents Nodule 
Formation and Development of Preneoplastic Foci of Altered 
Hepatocytes in Rats 
Yves Horsman, Bruxelles, Belgium 
 
Blood Sugar Test: Non-Invasive Diagnosis for Liver Diseases 
Chitty Chen, Ghent, Belgium 
 
HBV Genome Oncogenic Mutations in Chinese HCC Related to Chronic 
HBV Infection 
Fengmin Lu ( ), Beijing 
 
16:05-16:30      Coffee break 
 
16:30-18:05 Meeting Room 201  A Review for Liver Transplantation in China 
Shichun Lu ( ), Beijing 
 
Risks and results of the living related liver transplantation in Europe 
Bernard de Hemptinne, Ghent, Belgium 
 
Shear Stress: A Trigger for Liver Regeneration Cascade? 
Yedong Fan, Ghent, Belgium 
 
Contrast Enhanced Magnetic Resonance Imaging as Virtual Biopsy for 
Diagnosis and Therapeutic Assessment of Liver Malignancies 
Yicheng Ni, Leuven, Belgium 
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15 NOVEMBER 2008, SATURDAY 
 
 
08:00-08:30 Convention Hall 2  Presidential Lecture 1 
 
The Construction and Development of New Type Infectious Hospital 
        Yu Mao ( ), Beijing 
 
08:30-08:45      BREAK 
 
08:45-10:00 Convention Hall 2  Concurrent Session 1 - Management of Hepatitis B 
 
        Occult HBV Infection 
        Shiv K. Sarin, New Delhi, India        
Treatment of Hepatitis B Virus 
        Masao Omata, Tokyo, Japan 
From the Pathogenesis to the Therapeutic Strategy of Chronic Hepatitis B 
Infection 
        Guiqiang Wang ( ), Beijing 
             
10:00-10:45 Convention Hall 2  Industry Supported Satellite Symposium (GSK) 
 
08:45-10:45 Meeting Room 201  Concurrent Session 2 - Bacterial Infection 
 
Prevalence of dupA of Helicobacter Pylori Strains Isolated from Shanghai 
Patients and Its Clinical Implications 
        Hong Lu ( ), Shanghai 
        Antimicrobial Susceptibility Testing through EUCAST 
        Gunnar Kahlmeter, Vaxjo, Sweden 
Laribacter Hongkongensis: From Discovery to Complete Genome 
Sequence 
        Patrick C.Y. Woo ( ), Hong Kong 
Antibiotic Resistance in Gram-Negative Pathogens: Dealing with 
Untreatable Infections 
        Paul A. Tambyah, Singapore 
        Two Stage Theory Pathogenic Mechanism of Streptococcus suis  
        Jianguo Xu ( ), Beijing 
         
08:45-10:45 Meeting Room 311  Concurrent Session 3 - HIV – Overview 
 
Prevalence of Drug Resistance HIV-1 in Rural Areas of Hubei Province in 
the People’s Republic of China 
Zhiwei Chen ( ), Hong Kong 
Molecular Epidemiology of Drug Resistant HIV-1 in Hong Kong 
Wing-Cheong Yam ( ), Hong Kong 
Opportunistic Infections in AIDS : Thai Experience 
Boonmee Sathapatayavongs, Bangkok, Thailand 
HIV-Specific T-Cell Responses in a Cohort of Slow Progressors in China 
Tao Dong, Oxford, United Kingdom 
Outcomes and Challenges of the China National Free Antiretroviral 
Treatment Program 
Fujie Zhang ( ), Beijing 
 
10:45-11:15 Meeting Room 201  Plenary Session 1 
 
11:15-11:30      BREAK 
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11:30-13:00 Convention Hall 2  Industry Supported Satellite Symposium (BMS) 
 
13:00-13:30 Convention Hall 2  Presidential Lecture 2 
 
Overview of MRSA 
Giuseppe Cornaglia, Verona, Italy 
 
13:30-15:30 Convention Hall 2  Concurrent Session 4 - Immunology and Virology 
 
The Immunology of HBV Infection 
John M. Vierling, Houston, United States 
Virologic Techniques for the Diagnosis and Monitoring of Hepatitis B 
George K.K. Lau ( ), Hong Kong 
New Cell Culture and Mouse Models of HBV Replication 
Hong Tang ( ), Chengdu 
Association between Epidermal Growth Factor Gene Polymorphisms and 
the Risk of Hepatocellular Carcinoma in Patients with Hepatitis B Virus 
Chronic Infection 
Fengmin Lu ( ), Beijing 
The Natural History of Infections Caused by Varicella-Zoster Virus (VZV): 
Primary Infection, Transmission, Latency, and Reactivation 
Michael D. Gershon, New York, United States 
 
13:30-15:30 Meeting Room 201  Concurrent Session 5 - Usage of Antibiotics and MRSA 
     
Antibiotic Application in China 
Yonghong Xiao ( ), Beijing 
Prenyltransferases as Targets for Antibiotic Drug Discovery 
Andrew H.J. Wang ( ), Taipei 
Antibiotic Use and Epidemiology Characteristic of Methicillin-Resistant 
Staphylococcus aureus in Chinese Pediatrics 
Xuzhuang Shen ( ), Beijing 
Molecular Identification and Typing of Methicillin-Resistant 
Staphylococcus aureus (MRSA) 
Margaret Ip ( ), Hong Kong 
Resistance in S. aureus: Should Epidemiology Patterns Influence the Hui 
Choice of Therapy? 
Hui Wang ( ), Beijing 
 
13:30-15:30 Meeting Room 311  Concurrent Session 6 - Tuberculosis Updates 
 
Extensively Drug Resistant Tuberculosis (XDR-TB) – An Overview  
Robert C. Read, Sheffield, United Kingdom 
Latent Infection of M. Tuberculosis in China  
Wenhong Zhang ( ), Shanghai 
Epidemiology of Mycobacterium Tuberculosis Genotypes in Different 
Ethnic and Age Populations in Taiwan  
Ih-Jen Su ( ), Tainan 
Recent Advances in the Diagnosis of TB 
Giorgio Roscigno, Geneva, Switzerland 
Molecular Diagnosis of Tuberculosis  
Sang Nae Cho, Seoul, Korea 
Detection of Mycobacterium tuberculosis infection using 
Interferon-Gamma Release Assay in Shenzhen, China  
Xinchun Chen ( ), Shenzhen 
 
15:30-16:00 Convention Hall 2  Presidential Lecture 3 
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Towards an HIV Vaccine - What is Protective Immunity against HIV 
Infection? 
Sarah Rowland-Jones, Oxford, United Kingdom 
 
16:00-17:30 Meeting Room 201A  Free Paper Presentation 1 – Tuberculosis 
 
16:00-17:30 Meeting Room 201B  Free Paper Presentation 2 – Hepatitis B 
 
16:00-17:30 Meeting Room 311C  Free Paper Presentation 3 – Basic Science and Animal Models 
 
17:30-18:30 Convention Hall 2  Industry Supported Satellite Symposium (Schering Plough) 
 
16 NOVEMBER 2008, SUNDAY 
 
 
08:00-08:30 Convention Hall 2  Presidential Lecture 4  
 
Vaccination against Varicella and Zoster: History and Experience in the 
United States        
Anne A. Gershon, New York, United States 
 
08:30-08:45      BREAK 
 
08:45-10:45 Convention Hall 2  Concurrent Session 7 - Understanding HCV 
 
Pathogenesis and Clinical Impact of Insulin Resistance in HCV Infection
 Alfredo Alberti, Padova, Italy 
Regulation of a Hepatitis C Virus Co-Receptor Claudin-1 in Hepatocytes 
Takashi Kojima, Sapporo, Japan 
Assessment of Specific Antibodies to F Protein in Sera of Chinese 
Hepatitis C Patients Treated with Interferon plus Ribavarin  
Xinxin Zhang ( ), Shanghai 
Efficacy and Relapse: Peginterferon Alpha-2a plus Ribavirin Combination 
Therapy in Chinese Patients with Chronic Hepatitis C in Clinical Practice 
Xiaoguang Dou ( ), Shenyang 
 
        
08:45-10:45 Meeting Room 201  Concurrent Session 8 - Nosocomial Infection and Public Health 
 
Rational Management of Community Acquired Pneumonia  
Bing Lam ( ), Hong Kong 
Clinical Management of Severe Respiratory Infections in Adult 
Hospitalized Patients  
Nelson L.S. Lee ( ), Hong Kong 
Creative Hand Hygiene Campaigns 
Moi-Lin Ling, Singapore 
The Clinical Characteristics and Therapy for SARS  
Limin Guo ( ), Beijing 
Strategy for Recalcitrant MRSA Infections - An Evolving Clinical 
Challenge 
Po-Ren Hsueh ( ), Taipei 
 
08:45-10:45 Meeting Room 311  Concurrent Session 9 –  
End-Stage Liver Diseases and Complications 
 
Cirrhotic Cardiomyopathy: An Unappreciated Complication of End-Stage 
Liver Disease  
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Samuel S. Lee, Calgary, Canada 
Infectious Complications in Acute Liver Failure  
Vikram Bhatia, New Delhi, India 
TIPS (Transjugular Intrahepatic Portosystemic Shunts) in the Treatment 
of Complications of Portal Hypertension  
Duncan M. Brooks, Heidelberg, Australia  
fgl2 Molecule, Micro-Circulation Disorder and Infectious Diseases 
Qin Ning ( ), Wuhan 
TBC 
Yuming Wang ( ), Chongqing 
 
 
10:45-11:15 Meeting Room 201  Plenary Session 2 
 
11:15-11:30      BREAK 
 
11:30-13:00 Convention Hall 2  Industry Supported Satellite Symposium (Novartis) 
 
13:00-13:30 Convention Hall 2  Presidential Lecture 5 
 
Pathogenesis and Treatment of Bird Flu  
Kwok-Yung Yuen ( ), Hong Kong 
 
13:30-15:30 Convention Hall 2  Concurrent Session 10 - Management of Hepatitis C 
 
Treatment of Chronic Hepatitis C in Taiwan  
Jia-Horng Kao ( ), Taipei 
Optimizing HCV Antiviral Treatment: Reducing Treatment Duration 
Samuel S. Lee, Calgary, Canada 
Optimizing HCV Antiviral Treatment: Lengthening Treatment Duration  
Lai Wei ( ), Beijing 
TBC 
Hong Ren ( ), Chongqing 
Management of Chronic Hepatitis B and C in HIV-Coinfected Patients  
Teerha Piratvisuth, Hat Yai, Thailand 
 
    
13:30-15:30 Meeting Room  201  Concurrent Session 11 –  
Emerging Infectious Diseases: Pathogen in Animal and Human 
 
Death and Severity of Meningococcal Disease - Influence of Microbial 
Phenotype, Host Genotype and Environment  
Robert C. Read, Sheffield, United Kingdom 
Emerging Bartonella in Animal and Human in China  
Qiyong Liu ( ), Beijing 
More and More Human and Animal Coronaviruses 
Patrick C.Y. Woo ( ), Hong Kong 
The Interaction between M1 Protein of Influenza Virus and Host Cell 
Factors 
Wenjun Liu ( ), Beijing 
Structural Study of RNA Polymerase PA Subunit from an Avian Influenza 
Virus 
Yingfang Liu ( ), Beijing 
 
 
13:30-15:30 Meeting Room 311  Concurrent Session 12 - Vaccination: Prevention and Beyond 
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The Changing Molecular Epidemiology of Hepatitis A Virus Infection in 
Jerusalem Following Implementation of Universal Vaccination in 
1999-2004 
Daniel Shouval, Jerusalem, Israel 
Epidemiology and Prevention of HPV Related Diseases in China 
Youlin Qiao ( ), Beijing 
Development of Therapeutic Vaccine against HBV by the Use of Adjuvant 
to Boost the Cell-Mediated Immunity  
Bin Wang ( ), Beijing 
Sequential Vaccination with Heterolgous HIV immunogens stimulate 
cross-reative T-cell and neutralization antibodies 
Jianqing Xu ( ), Shanghai 
 
    
15:30-16:30      BREAK and POSTER SESSION 
 
16:30-18:00  Meeting Room 201A  Free Paper Presentation 4 – Infectious Diseases and Public Health 
 
16:30-18:00  Meeting Room 201B  Free Paper Presentation 5 – HIV/AIDS and Viral Infection 
 
16:30-18:00  Meeting Room 311C  Free Paper Presentation 6 – Hepatitis C 
 
 
17 NOVEMBER 2008, MONDAY 
 
 
08:00-08:45 Meeting Room 201  Plenary Session 3 
 
08:45-10:45 Convention Hall 2  Concurrent Session 13 - Viral Hepatitis and Hepatocellular Carcinoma 
 
Viral Factors of Hepatocellular Carcinoma in Chronic Hepatitis B 
Henry L.Y. Chan ( ), Hong Kong 
Hepatitis B and C Viral-Cellular Interactions in the Pathogenesis of 
Hepatocellular Carcinoma 
Jack R. Wands, Providence, United States 
How to Predict HCC Development in Patients with Chronic Hepatitis B 
Viral Infection? 
Kwang Hyub Han, Seoul, Korea 
 
        
08:45-10:45 Meeting Room 201  Concurrent Session 14 - Fungal Infection 
 
Fungal Infections: Insights from the Bench-Side  
Mamie Hui ( ), Hong Kong 
Invasive Fungal Infections in Asia-Pacific Region 
       Po-Ren Hsueh ( ), Taipei 
Genotype Distribution of Candida Albicans in China 
Fengyan Bai ( ), Beijing  
Non-Culture Diagnosis of Fungal Infection 
Ruoyu Li ( ), Beijing 
Systemic Mycoses of Local Importance 
Boonmee Sathapatayavongs, Bangkok, Thailand 
 
08:45-10:45 Meeting Room 311  Concurrent Session 15 - HIV / AIDS Treatment - Never Simple 
 
The Changes and Distributions Status of Opportunistic Infections during 
6 months after HAART Initiation 
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Hongxin Zhao ( ), Beijing 
Salvage Antiretroviral Regimens in the Resource Limited Settings 
Christopher K.C. Lee, Sungai Buloh, Malaysia 
Practice Guidelines for the Management of Patients with AIDS and 
Cryptococcal Meningitis  
Hongzhou Lu ( ), Shanghai 
Specific T-cell Responses to ESAT-6 and CFP-10 in Chinese HIV Positive 
Individuals without Active TB Disease. A Way to Find the Latent TB 
Infection in China? 
Wenhui Lun ( ), Beijing 
 
 
10:45-11:15 Meeting Room 201  Plenary Session 4 
 
11:15-11:30      BREAK 
 
11:30-13:00 Convention Hall 2  Industry Supported Satellite Symposium (Roche) 
 
13:00-13:30 Convention Hall 2  Presidential Lecture 6 
 
Viral Hepatitis B: Where We Are and Where We Are Going 
Jidong Jia ( ), Beijing 
 
13:30-15:30 Convention Hall 2  Concurrent Session 16 - Advanced Treatment Strategies of Hepatitis B 
 
New Paradigms for the Treatment of Hepatitis B 
Morris Sherman, Toronto, Canada 
The Host Immunity Response of Hepatitis B Patients After Adefovir 
Dipivoxil and Entecavir Therapy 
Junqi Niu ( ), Changchun 
How to Manage and Prevent Drug Resistant HBV 
Richard M.F. Yuen ( ), Hong Kong 
    
13:30-15:30 Meeting Room 201  Concurrent Session 17 - Parasitology and Tropical Medicine 
 
New Developments in the Pathophysiology and Diagnosis of Dengue 
Fever and its Complications  
Vincent T.K. Chow, Singapore 
Temporal-Spatial Analysis of Dengue Fever Epidemic in Guangdong 
Province of China, 2001-2006  
Qiyong Liu ( ), Beijing 
Phylogenic status of Pneumocystis Derived from Mongolian Gerbil 
Siqi Lu ( ), Beijing 
Proteomic Analysis of CSF in Patients with Neurocysticercosis 
Yanping Xue ( ), Beijing 
        TBC 
Linhua Tang ( ), Shanghai 
 
13:30-15:30 Meeting Room 311  Concurrent Session 18 –  
Biotechnology: From the Micro-world to Real-world  
 
A New Mouse Model for Investigating Tolerance to Hepatitis B Virus: The 
Important Role of HBV Core Protein 
Pei-Jer Chen ( ), Taipei  
Gene Therapy of Chronic Hepadnavirus Infection 
Jesus Prieto, Pamplona, Spain 
Increased Regulatory T Cells Impair Adaptive Immunity and Favor 
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Disease Progression in Chronic HBV-infected Patients 
Fusheng Wang ( ), Beijing 
The Evolution of the Innate Immune System: T Cells Are Required for 
Homeostatic Innate Inflammatory Response to Viral Infection 
Hong Tang ( ), Beijing 
TBC 
Jinming Li ( ), Beijing 
 
